{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:42:09Z","timestamp":1793464929844,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20H00665"],"award-info":[{"award-number":["20H00665"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.actbio.2021.11.027","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T20:55:02Z","timestamp":1637700902000},"page":"275-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment"],"prefix":"10.1016","volume":"140","author":[{"given":"Yasuyuki","family":"Naito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yoshinouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Sorayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiya","family":"Matsusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.actbio.2021.11.027_bib0001","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41573-019-0048-x","article-title":"Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models","volume":"19","author":"Weaver","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.actbio.2021.11.027_bib0002","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1389200219666180523095355","article-title":"Models of drug induced liver injury (DILI)\u2013current issues and future perspectives","volume":"19","author":"Kuna","year":"2018","journal-title":"Curr. Drug Metab."},{"issue":"15","key":"10.1016\/j.actbio.2021.11.027_bib0003","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1177\/1535370216657448","article-title":"Cell sources for in vitro human liver cell culture models","volume":"241","author":"Zeilinger","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"11","key":"10.1016\/j.actbio.2021.11.027_bib0004","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1517\/17425255.2014.967680","article-title":"Competency of different cell models to predict human hepatotoxic drugs","volume":"10","author":"Gomez-Lechon","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"5","key":"10.1016\/j.actbio.2021.11.027_bib0005","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hep.28780","article-title":"Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation","volume":"64","author":"Lauschke","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0006","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1124\/dmd.105.009118","article-title":"Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport","volume":"34","author":"Bi","year":"2006","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.actbio.2021.11.027_bib0007","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1007\/s00204-016-1758-z","article-title":"Bile canaliculi formation and biliary transport in 3D sandwich-cultured hepatocytes in dependence of the extracellular matrix composition","volume":"90","author":"Deharde","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.actbio.2021.11.027_bib0008","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.actbio.2021.11.027_bib0009","doi-asserted-by":"crossref","first-page":"35434","DOI":"10.1038\/srep35434","article-title":"Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability","volume":"6","author":"Hendriks","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.actbio.2021.11.027_bib0011","doi-asserted-by":"crossref","DOI":"10.3727\/105221620X15868728381608","article-title":"Microscale collagen and fibroblast interactions enhance primary human hepatocyte functions in 3-dimensional models","author":"Kukla","year":"2020","journal-title":"Gene Expr."},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/toxsci\/kfs326","article-title":"Use of micropatterned cocultures to detect compounds that cause drug-induced liver injury in humans","volume":"132","author":"Khetani","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0013","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/j.xphs.2017.05.010","article-title":"Recent progress in hepatocyte culture models and their application to the assessment of drug metabolism, transport, and toxicity in drug discovery: the value of tissue engineering for the successful development of a microphysiological system","volume":"106","author":"Tetsuka","year":"2017","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0014","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1021\/bp00009a007","article-title":"Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration","volume":"7","author":"Dunn","year":"1991","journal-title":"Biotechnol. Prog."},{"issue":"2","key":"10.1016\/j.actbio.2021.11.027_bib0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4174\/astr.2017.92.2.67","article-title":"Three-dimensional (3D) printing of mouse primary hepatocytes to generate 3D hepatic structure","volume":"92","author":"Kim","year":"2017","journal-title":"Ann. Surg. Treat. Res."},{"issue":"6","key":"10.1016\/j.actbio.2021.11.027_bib0016","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible rat model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.actbio.2021.11.027_bib0017","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.clinre.2016.01.006","article-title":"Sinusoidal obstruction syndrome","volume":"40","author":"Valla","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"28","key":"10.1016\/j.actbio.2021.11.027_bib0018","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.3748\/wjg.v25.i28.3753","article-title":"Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes","volume":"25","author":"Yang","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.actbio.2021.11.027_bib0019","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1124\/dmd.107.018358","article-title":"Species differences in the response of liver drug-metabolizing enzymes to (S)-4-O-tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric acid (EMD 392949) in vivo and in vitro","volume":"36","author":"Richert","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.actbio.2021.11.027_bib0020","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/aa70c7","article-title":"3D liver membrane system by co-culturing human hepatocytes, sinusoidal endothelial and stellate cells","volume":"9","author":"Ahmed","year":"2017","journal-title":"Biofabrication"},{"issue":"7","key":"10.1016\/j.actbio.2021.11.027_bib0021","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/term.2102","article-title":"Fabrication of functional 3D hepatic tissues with polarized hepatocytes by stacking endothelial cell sheets in vitro","volume":"11","author":"Kim","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.actbio.2021.11.027_bib0022","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.biomaterials.2017.02.034","article-title":"Construction of three-dimensional vascularized functional human liver tissue using a layer-by-layer cell coating technique","volume":"133","author":"Sasaki","year":"2017","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0023","first-page":"1","article-title":"Microengineered cell and tissue systems for drug screening and toxicology applications: evolution of in-vitro liver technologies","volume":"3","author":"Usta","year":"2015","journal-title":"Technology (Singap World Sci)"},{"issue":"4","key":"10.1016\/j.actbio.2021.11.027_bib0024","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jbm.a.35292","article-title":"Construction of three-dimensional liver tissue models by cell accumulation technique and maintaining their metabolic functions for long-term culture without medium change","volume":"103","author":"Matsuzawa","year":"2015","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.actbio.2021.11.027_bib0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.actbio.2016.01.033","article-title":"Development of vascularized iPSC derived 3D-cardiomyocyte tissues by filtration Layer-by-Layer technique and their application for pharmaceutical assays","volume":"33","author":"Amano","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2021.11.027_bib0026","unstructured":"S. Kitano, S. Irie, M. Matsusaki, Cell viscous assembly methos, (2021)."},{"issue":"6","key":"10.1016\/j.actbio.2021.11.027_bib0027","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2133\/dmpk.DMPK-10-RG-047","article-title":"In vitro evaluation of cytochrome P450 and glucuronidation activities in hepatocytes isolated from liver-humanized mice","volume":"25","author":"Yamasaki","year":"2010","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.actbio.2021.11.027_bib0028","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/toxsci\/kfz229","article-title":"High-throughput screening to evaluate inhibition of bile acid transporters using human hepatocytes isolated from chimeric mice","volume":"173","author":"Kohara","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237809","article-title":"Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: novel, long-term, functional two-dimensional in vitro tool for developing new drugs","volume":"15","author":"Yamasaki","year":"2020","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.actbio.2021.11.027_bib0030","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1007\/s00204-016-1845-1","article-title":"Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man","volume":"90","author":"Dragovic","year":"2016","journal-title":"Arch. Toxicol."},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0031","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1007\/s00204-020-02798-z","article-title":"Monocrotaline-induced liver toxicity in rat predicted by a combined in vitro physiologically based kinetic modeling approach","volume":"94","author":"Suparmi","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0032","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0033","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","article-title":"Metascape provides a biologist-oriented resource for the analysis of systems-level datasets","volume":"10","author":"Zhou","year":"2019","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.actbio.2021.11.027_bib0034","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"issue":"15-16","key":"10.1016\/j.actbio.2021.11.027_bib0035","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.drudis.2011.05.007","article-title":"FDA-approved drug labeling for the study of drug-induced liver injury","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.actbio.2021.11.027_bib0036","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.drudis.2016.02.015","article-title":"DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans","volume":"21","author":"Chen","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"7","key":"10.1016\/j.actbio.2021.11.027_bib0037","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0038","doi-asserted-by":"crossref","DOI":"10.1117\/1.OE.52.3.037204","article-title":"Retinal blood vessel detection using wavelet-matched filter","volume":"52","author":"Widjaja","year":"2013","journal-title":"Opt. Eng."},{"key":"10.1016\/j.actbio.2021.11.027_bib0039","doi-asserted-by":"crossref","first-page":"44356","DOI":"10.1038\/srep44356","article-title":"Immunofluorescence identifies distinct subsets of endothelial cells in the human liver","volume":"7","author":"Strauss","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.actbio.2021.11.027_bib0040","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/toxsci\/kfv152","article-title":"Setting clinical exposure levels of concern for drug-induced liver injury (DILI) using mechanistic in vitro assays","volume":"147","author":"Shah","year":"2015","journal-title":"Toxicol. Sci."},{"issue":"7","key":"10.1016\/j.actbio.2021.11.027_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235745","article-title":"Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity","volume":"15","author":"Nudischer","year":"2020","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0042","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.bjc.6603097","article-title":"High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy","volume":"94","author":"de Jonge","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0043","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0168-8278(03)00231-9","article-title":"Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids","volume":"39","author":"Chojkier","year":"2003","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0044","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1021\/nl0613555","article-title":"Heparin binding nanostructures to promote growth of blood vessels","volume":"6","author":"Rajangam","year":"2006","journal-title":"Nano Lett."},{"issue":"5","key":"10.1016\/j.actbio.2021.11.027_bib0045","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/0955-0674(90)90084-R","article-title":"The affinity of fibroblast growth factors (FGFs) for heparin; FGF-heparan sulfate interactions in cells and extracellular matrix","volume":"2","author":"Klagsbrun","year":"1990","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.actbio.2021.11.027_bib0046","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1083\/jcb.141.7.1659","article-title":"Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis","volume":"141","author":"Seghezzi","year":"1998","journal-title":"J. Cell Biol."},{"issue":"22","key":"10.1016\/j.actbio.2021.11.027_bib0047","doi-asserted-by":"crossref","first-page":"11927","DOI":"10.1039\/D0NR01570A","article-title":"Interaction of vascular endothelial growth factor and heparin quantified by single molecule force spectroscopy","volume":"12","author":"Zhang","year":"2020","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0048","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1083\/jcb.104.3.585","article-title":"A cell surface receptor complex for collagen type I recognizes the Arg-Gly-Asp sequence","volume":"104","author":"Dedhar","year":"1987","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0049","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","article-title":"Heparin-protein interactions","volume":"41","author":"Capila","year":"2002","journal-title":"Angewandte Chemie Int. Ed."},{"issue":"1-2","key":"10.1016\/j.actbio.2021.11.027_bib0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1582-4934.2009.00871.x","article-title":"Heparin: an intervenor in cell communication","volume":"14","author":"Xu","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0051","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mabi.201400415","article-title":"Cell\u2013cell crosslinking by bio-molecular recognition of heparin-based layer-by-layer nanofilms","volume":"15","author":"Nishiguchi","year":"2015","journal-title":"Macromol. Biosci."},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0052","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/j.2040-4603.2013.tb00490.x","article-title":"Hepatocyte polarity","volume":"3","author":"Treyer","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.actbio.2021.11.027_bib0053","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-62703-125-7_17","article-title":"Long-term culture and coculture of primary rat and human hepatocytes","volume":"945","author":"Shulman","year":"2013","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.actbio.2021.11.027_bib0054","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/cts.12969","article-title":"Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation","volume":"14","author":"Rubiano","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.actbio.2021.11.027_bib0055","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-3305-3-60","article-title":"Hepatic stellate cells and parasite-induced liver fibrosis","volume":"3","author":"Anthony","year":"2010","journal-title":"Parasit. Vectors"},{"issue":"9","key":"10.1016\/j.actbio.2021.11.027_bib0056","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s00204-018-2269-x","article-title":"Comprehensive analysis of serum microRNAs in hepatic sinusoidal obstruction syndrome (SOS) in rats: implication as early phase biomarkers for SOS","volume":"92","author":"Takeuchi","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.actbio.2021.11.027_bib0057","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.fct.2019.04.057","article-title":"Development of a two-layer transwell co-culture model for the in vitro investigation of pyrrolizidine alkaloid-induced hepatic sinusoidal damage","volume":"129","author":"Lu","year":"2019","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.actbio.2021.11.027_bib0058","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/0041-0101(95)00169-7","article-title":"A simple procedure for determining the aqueous half-lives of pyrrolic metabolites of pyrrolizidine alkaloids","volume":"34","author":"Cooper","year":"1996","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.actbio.2021.11.027_bib0059","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bbmt.2013.04.005","article-title":"Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes","volume":"19","author":"Rezvani","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.actbio.2021.11.027_bib0060","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00001721-199707000-00003","article-title":"The antithrombotic effects of recombinant human soluble thrombomodulin (rhsTM) on tissue factor-induced disseminated intravascular coagulation in crab-eating monkeys (Macaca fascicularis)","volume":"8","author":"Mohri","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"6","key":"10.1016\/j.actbio.2021.11.027_bib0061","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.21873\/invivo.11393","article-title":"Soluble thrombomodulin attenuates endothelial cell damage in hepatic sinusoidal obstruction syndrome","volume":"32","author":"Takada","year":"2018","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.actbio.2021.11.027_bib0062","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41409-018-0304-4","article-title":"Clinical effects of recombinant thrombomodulin and defibrotide on sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation","volume":"54","author":"Yakushijin","year":"2019","journal-title":"Bone Marrow Transplant."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121007753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706121007753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:47:41Z","timestamp":1761673661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706121007753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":62,"alternative-id":["S1742706121007753"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2021.11.027","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constructing vascularized hepatic tissue by cell-assembled viscous tissue sedimentation method and its application for vascular toxicity assessment","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2021.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}